Equity Valuation for Pharmaceutical Companies
By External Provider
About this course
Master pharma stock analysis, financial modeling, and equity valuation techniques used by professional equity research analysts. Learn how to evaluate pharmaceutical companies, build financial projections, and estimate intrinsic stock value using real-world financial data. This course provides a practical, step-by-step approach to equity research in the pharmaceutical sector through the real-world case study of Claris Lifesciences. You’ll explore pharma industry dynamics, understand injectables and infusion markets, and learn how business models influence financial performance and investment potential. Through structured lessons and hands-on financial analysis, you’ll examine income statements, identify cost drivers, forecast financial performance, and build valuation models used in professional equity research. The course also covers advanced finance concepts including beta calculation, Weighted Average Cost of Capital (WACC), free cash flow analysis, and discounted cash flow (DCF) valuation techniques. A unique feature of this course is its strong focus on practical application rather than theory alone. By linking financial statements with forecasting and valuation frameworks, learners gain real-world analytical skills used in investment banking, equity research, and financial analysis roles. By the end of the course, you’ll be able to independently analyze pharmaceutical companies, estimate intrinsic stock value, interpret investment opportunities, and make informed equity investment decisions with confidence.
What you will learn
- Analyze pharmaceutical companies using equity research techniques.
- Build financial projections and valuation models using DCF and WACC.
- Estimate intrinsic stock value and evaluate investment opportunities.